- Previous Close
3.5500 - Open
3.5100 - Bid 3.5700 x --
- Ask 3.5800 x --
- Day's Range
3.5100 - 3.6300 - 52 Week Range
2.7600 - 4.9200 - Volume
12,481,600 - Avg. Volume
10,618,976 - Market Cap (intraday)
2.827B - Beta (5Y Monthly) 0.41
- PE Ratio (TTM)
-- - EPS (TTM)
-0.3000 - Earnings Date --
- Forward Dividend & Yield 0.07 (1.85%)
- Ex-Dividend Date Jun 7, 2024
- 1y Target Est
--
Guizhou Yibai Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. It offers products in the form of capsules, tablets, granules, syrups, small-volume injections, freeze-dried powder injections, pills, and oral solutions in the areas of tumor system, cerebrovascular, respiratory system, rheumatism, digestive system, pediatric, gynecological, anti-infection, anti-inflammatory, analgesic, and other diseases. The company was founded in 1995 and is based in Guiyang, China.
www.gzcci.com5,509
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 600594.SS
View MorePerformance Overview: 600594.SS
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 600594.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 600594.SS
View MoreValuation Measures
Market Cap
2.83B
Enterprise Value
3.07B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.18
Price/Book (mrq)
1.07
Enterprise Value/Revenue
1.28
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-9.83%
Return on Assets (ttm)
-2.28%
Return on Equity (ttm)
-7.98%
Revenue (ttm)
2.4B
Net Income Avi to Common (ttm)
-235.62M
Diluted EPS (ttm)
-0.3000
Balance Sheet and Cash Flow
Total Cash (mrq)
619.88M
Total Debt/Equity (mrq)
31.14%
Levered Free Cash Flow (ttm)
241.08M